Flamen P - Search Results

1

Reducing loss of image quality because of the attenuation artifact in uncorrected PET whole-body images.

Nuyts J, Stroobants S, Dupont P, Vleugels S, Flamen P, Mortelmans L. Nuyts J, et al. Among authors: flamen p. J Nucl Med. 2002 Aug;43(8):1054-62. J Nucl Med. 2002. PMID: 12163632 Free article.

2

Understanding the Radiobiological Mechanisms Induced by ¹⁷⁷Lu-DOTATATE in Comparison to External Beam Radiation Therapy.

Delbart W, Karabet J, Marin G, Penninckx S, Derrien J, Ghanem GE, Flamen P, Wimana Z. Delbart W, et al. Among authors: flamen p. Int J Mol Sci. 2022 Oct 15;23(20):12369. doi: 10.3390/ijms232012369. Int J Mol Sci. 2022. PMID: 36293222 Free PMC article.

3

Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.

Van Laere K, Ceyssens S, Van Calenbergh F, de Groot T, Menten J, Flamen P, Bormans G, Mortelmans L. Van Laere K, et al. Among authors: flamen p. Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):39-51. doi: 10.1007/s00259-004-1564-3. Epub 2004 Aug 10. Eur J Nucl Med Mol Imaging. 2005. PMID: 15309329

4

Lhermitte-Duclos disease: 11C-methionine positron emission tomography data in 4 patients.

Van Calenbergh F, Vantomme N, Flamen P, Demaerel P, Sciot R, Legius E, Mortelmans L, Plets C. Van Calenbergh F, et al. Among authors: flamen p. Surg Neurol. 2006 Mar;65(3):293-6; discussion 296-7. doi: 10.1016/j.surneu.2005.06.031. Surg Neurol. 2006. PMID: 16488255

5

Positron emission tomography in colorectal cancer.

Flamen P. Flamen P. Best Pract Res Clin Gastroenterol. 2002 Apr;16(2):237-51. doi: 10.1053/bega.2001.0283. Best Pract Res Clin Gastroenterol. 2002. PMID: 11969236 Review.

6

Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?

Vrieze O, Haustermans K, De Wever W, Lerut T, Van Cutsem E, Ectors N, Hiele M, Flamen P. Vrieze O, et al. Among authors: flamen p. Radiother Oncol. 2004 Dec;73(3):269-75. doi: 10.1016/j.radonc.2004.10.001. Radiother Oncol. 2004. PMID: 15588870 Clinical Trial.

7

A plea for the elective inclusion of the brain in routine whole-body FDG PET.

Belhocine T, Weiner SM, Brink I, De Deyn PP, Roland J, Van der Borght T, Flamen P. Belhocine T, et al. Among authors: flamen p. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):251-6. doi: 10.1007/s00259-004-1729-0. Eur J Nucl Med Mol Imaging. 2005. PMID: 15692807 No abstract available.

8

Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET.

Huyge V, Garcia C, Vanderstappen A, Alexiou J, Gil T, Flamen P. Huyge V, et al. Among authors: flamen p. Clin Nucl Med. 2009 Jul;34(7):417-20. doi: 10.1097/RLU.0b013e3181a7d03c. Clin Nucl Med. 2009. PMID: 19542943

9

Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.

Necib H, Garcia C, Wagner A, Vanderlinden B, Emonts P, Hendlisz A, Flamen P, Buvat I. Necib H, et al. Among authors: flamen p. J Nucl Med. 2011 Mar;52(3):354-61. doi: 10.2967/jnumed.110.080150. J Nucl Med. 2011. PMID: 21345787 Free article.

10

18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.

Gebhart G, Gámez C, Holmes E, Robles J, Garcia C, Cortés M, de Azambuja E, Fauria K, Van Dooren V, Aktan G, Coccia-Portugal MA, Kim SB, Vuylsteke P, Cure H, Eidtmann H, Baselga J, Piccart M, Flamen P, Di Cosimo S. Gebhart G, et al. Among authors: flamen p. J Nucl Med. 2013 Nov;54(11):1862-8. doi: 10.2967/jnumed.112.119271. Epub 2013 Oct 3. J Nucl Med. 2013. PMID: 24092940 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters